A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy and Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer.
Phase of Trial: Phase II
Latest Information Update: 10 Dec 2015
At a glance
- Drugs Ontuxizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms MICRO
- Sponsors Morphotek
- 01 Dec 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Jun 2013 Trial Company changed from Morphotek to Eisai Inc, as Morphotek acquired by Eisai Inc.
- 24 May 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.